Dr. Mohan P Philip, M.D Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4221 Ridgecrest Rd, Ste 107, Greenville, TX 75402 Phone: 903-454-9976 Fax: 903-454-4509 |
News Archive
A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of the disease.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
After decades of declining US smoking rates overall, most remaining smokers have low income, no college education, no health insurance or a disability, according to research from the Colorado School of Public Health at CU Anschutz.
Medlytix, a national healthcare consulting firm, reported success this week in reaching a key half-billion dollar milestone - the total amount of money that its hospital clients have provided in financial assistance to more than a half-million patients nationwide by doing a better job of properly classifying charity care - in less than two years.
HAL Allergy B.V. today announced that it has successfully completed patient enrollment in its Phase II trial with SUBLIVAC FIX Phleum pratense.
› Verified 8 days ago